Quick Answer
AVANOS MEDICAL, INC. reported Total Revenue of $701.20 million for the year ending 2025.
- AVANOS MEDICAL, INC. showed an increase of +1.9% in Total Revenue from 2024 to 2025.
- This data is from AVANOS MEDICAL, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2017: $149.10 million | Q3 2017: $150.50 million | Q1 2018: $156.40 million | Q2 2018: $160.90 million | Q3 2018: $165.10 million | Q1 2019: $164.20 million | Q2 2019: $172.20 million | Q3 2019: $171.40 million | Q1 2020: $180.40 million | Q2 2020: $163.70 million | Q3 2020: $185.70 million | Q1 2021: $180.70 million | Q2 2021: $186.40 million | Q3 2021: $184.10 million | Q1 2022: $197.40 million | Q2 2022: $170.90 million | Q3 2022: $172.30 million | Q1 2023: $159.30 million | Q2 2023: $169.40 million | Q3 2023: $171.30 million | Q1 2024: $166.10 million | Q2 2024: $171.70 million | Q3 2024: $170.40 million | Q1 2025: $167.50 million | Q2 2025: $175.00 million | Q3 2025: $177.80 million.
- Over the full 10 years of available data (2016 to 2025), AVANOS MEDICAL, INC.'s Total Revenue has grown by 23.8%.
- Historical annual values: Fiscal year 2025: $701.20 million | Fiscal year 2024: $687.80 million | Fiscal year 2023: $673.30 million | Fiscal year 2022: $684.10 million | Fiscal year 2021: $587.00 million | Fiscal year 2020: $714.80 million | Fiscal year 2019: $697.60 million | Fiscal year 2018: $652.30 million | Fiscal year 2017: $611.60 million | Fiscal year 2016: $566.20 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: